Founded in 1992, Medconn specializes in the R&D, manufacturing, marketing and service of in vitro diagnostic products. Medconn is headquartered in Shanghai, China, with its business covering most provinces, cities and regions in China, and its products cover such subdivided fields as HbA1c Analyser, Biochemistry, Immunoassay and POCT.

In 2019, the company rebuilt the "Medconn Diagnostics" brand, integrate and improve the product system, and improve the research and development ability and service quality. Medconn diagnosis brand includes four companies: Shanghai Meconn Diagnostics Technology Co., Ltd., Shanghai Medconn Medical Technology Co., Ltd. Shanghai Medconn Diagnostics Technology Co., Ltd. And Beijing Medconn Medical Devices Co., Ltd. Shanghai Medconn Diagnostics Technology Co., Ltd. Assumes the function of marketing center, responsible for sales and services, while the other three companies assume the functions of R&D and production.

Medconn Diagnostics industrial park is located in Jinshan District, Shanghai, covering an area of nearly 40, 000 square meters, integrating R&D, production, warehousing and logistics functions. By the end of 2019, Medconn Diagnostic's R&D system had obtained 9 invention patents, 59 utility model patents, 6 design patents, 7 software Copyrights, 12 Certificates of Transformation of High-tech achievements and other independent intellectual property rights. Medconn Diagnostic's production system has 100, 000 level purification workshops and 9, 500 square meters cleaning workshops in line with GMP standards, and has passed ISO9001 quality management system, ISO13485 medical device quality management system and other international certifications.

In the future, Medconn Diagnostics will continue to adhere to the customer-oriented business philosophy, and continuously improve the product and service quality through continuous technological innovation and service innovation, so as to contribute to the vigorous development of IVD industry.